TCG Crossover Management, LLC logo

TCG Crossover Management, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for TCG Crossover Management, LLC with $2.0B in long positions as of Q3 2025, 61% allocated to Healthcare, and 67% concentrated in top 10 positions.

Portfolio Value
$2.0B
Top 10 Concentration
67%
Top Sector
Healthcare (61%)
US Exposure
100%
Market Cap Focus
Small Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 61.30%Healthcare
Healthcare
61.30%

Industry Breakdown

1 industry across all sectors

Biotechnology: 61.34%Biotechnology
Biotechnology
Healthcare
61.34%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 21.24%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 42.66%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 1.38%N/A (ETF or Unknown): 34.72%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
21.24%
Small Cap ($300M - $2B)
42.66%
Micro Cap ($50M - $300M)
1.38%
N/A (ETF or Unknown)
34.72%

Portfolio Concentration

Top 10 Holdings %
66.92%
Top 20 Holdings %
87.97%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
99.72%
International
0.278%
Countries
2
Largest Int'l Market
Switzerland - 0.28%
United States of America
99.72% ($2.0B)
38 holdings
Switzerland
0.28% ($5.6M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
6.7 quarters
Avg. Top 20
5.8 quarters
Avg. All Positions
4.8 quarters
Median Holding Period
4 quarters
Persistence Rate
58.97%
Persistent Holdings Weight
76.86%
Persistent Positions
23
Longest Held
Entrada Therapeutics, Inc. Common Stock logo
Entrada Therapeutics, Inc. Common StockTRDA - 15 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.85%
Avg. Position Weight
2.56%
Largest Position
ABVX
Abivax SA American Depositary SharesABVX - 30.14%
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 9.89%
Avg. Ownership Stake
3.12%
Ownership Stake >5%
11
Ownership Stake >1%
34

Historical (Since Q4 2021)

Avg. New Position
4.16%
Avg. Ownership Stake
3.56%
Largest Position
ABVX
Abivax SA American Depositary SharesABVX - 30.14% (Q3 2025)
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 37.57% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
12.0%
Value Traded
$240.74M
Positions Added
11
Positions Exited
9

Historical (Since Q4 2021)

Avg. Turnover Ratio
17.8%
Avg. Positions Added
5
Avg. Positions Exited
3
Highest Turnover
50.0%
Q4 2021
Lowest Turnover
3.7%
Q1 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.